PHARMACEUTICAL giant AstraZeneca has accepted that its COVID-19 vaccine "can, in very rare cases, cause TTS [Thrombosis with Thrombocytopenia Syndrome]", according to legal documents submitted yesterday to the United Kingdom High Court.
The AstraZeneca vaccine is no longer available in Australia from last month, as per ATAGI advice after it reviewed relevant evidence.
The above article was sent to subscribers in Pharmacy Daily's issue from 30 Apr 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Apr 24
